High-throughput cytotoxicity screening: hit and miss
Authors:
- Sharon P.M CrouchSCSharon P.M Crouch
- Kevin J SlaterKSKevin J Slater
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 6, 48-53
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Predicting human safety: screening and computational approachesDrug Discovery Today, 2000
- Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicityEuropean Journal of Biochemistry, 2000
- High-throughput screening: new technology for the 21st centuryCurrent Opinion in Chemical Biology, 2000
- Diversity screening versus focussed screening in drug discoveryDrug Discovery Today, 2000
- Biopharmaceutics and pharmacokinetics in drug researchInternational Journal of Pharmaceutics, 2000
- High-throughput and ultra-high-throughput screening: solution- and cell-based approachesCurrent Opinion in Biotechnology, 2000
- Toxicity Screening of a Combinatorial Library: Correlation of Cytotoxicity and Gene Induction to Compound StructureSLAS Discovery, 1999
- High Throughput Screening for Drug Discovery: Continually Transitioning into New TechnologySLAS Discovery, 1999
- Comparison of a Novel Redox Dye Cell Growth Assay to the ATP Bioluminescence AssayGynecologic Oncology, 1995
- Comparison of MTT and ATP‐based assays for the measurement of viable cell numberJournal of Bioluminescence and Chemiluminescence, 1995